Quarterly report pursuant to Section 13 or 15(d)

NOTE 7 - FAIR VALUE MEASUREMENTS (Tables)

v3.8.0.1
NOTE 7 - FAIR VALUE MEASUREMENTS (Tables)
9 Months Ended
Sep. 30, 2017
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis

The following tables summarize our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2017:

 

 

 

Balance at

September 30,

2017

 

 

Quoted Prices in Active Markets for Identical Assets

 

 

Significant Other Observable Inputs

 

 

Significant

Unobservable Inputs

 

 

 

 

 

 

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of liability for warrant derivative instruments

 

$

938,228

 

 

$

 

 

$

 

 

$

938,228

Schedule of Fair Value Liability of Warrant Derivative Instruments

The following is a roll forward through September 30, 2017 of the fair value liability of warrant derivative instruments:

 

 

 

Fair Value of

 

 

 

 

Liability for

 

 

 

 

Warrant

 

 

 

 

Derivative

 

 

 

 

Instruments

 

 

Balance at December 31, 2016

 

$

793,099

 

 

Initial fair value of warrant liability

 

 

2,046,348

 

 

Change in fair value included in other (income) loss

 

 

(1,901,219

)

 

Balance at September 30, 2017

 

$

938,228

 

 

Schedule of Fair Value Assumptions Used to Value Warrants

Thus, for the nine months ended September 30, 2017, the Company recognized a gain from the change in derivative liability of $1,901,219 included in the statement of operations under Other Income (Expense), Warrant Derivative Gain related to these warrant derivative instruments.


 

 

BSM Inputs

 

Warrants

 

 

 

 

 

For the Period

January 25, to September 30, 2017

 

Expected Volatility

 

58-142%

 

Expected Remaining Term

 

4.22-4.89 years

 

Risk Free Interest Rate

 

1.978-1.939%